Literature DB >> 29358320

Multiple Sclerosis Pathology.

Hans Lassmann1.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS), which gives rise to focal lesions in the gray and white matter and to diffuse neurodegeneration in the entire brain. In this review, the spectrum of MS lesions and their relation to the inflammatory process is described. Pathology suggests that inflammation drives tissue injury at all stages of the disease. Focal inflammatory infiltrates in the meninges and the perivascular spaces appear to produce soluble factors, which induce demyelination or neurodegeneration either directly or indirectly through microglia activation. The nature of these soluble factors, which are responsible for demyelinating activity in sera and cerebrospinal fluid of the patients, is currently undefined. Demyelination and neurodegeneration is finally accomplished by oxidative injury and mitochondrial damage leading to a state of "virtual hypoxia."
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29358320      PMCID: PMC5830904          DOI: 10.1101/cshperspect.a028936

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  81 in total

1.  Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.

Authors:  Igal Ifergan; Hania Kebir; Simone Terouz; Jorge I Alvarez; Marc-André Lécuyer; Steve Gendron; Lyne Bourbonnière; Ildiko R Dunay; Alain Bouthillier; Robert Moumdjian; Adriano Fontana; Arsalan Haqqani; Armelle Klopstein; Marco Prinz; Rubèn López-Vales; Thomas Birchler; Alexandre Prat
Journal:  Ann Neurol       Date:  2011-11       Impact factor: 10.422

2.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?

Authors:  Christina Marik; Paul A Felts; Jan Bauer; Hans Lassmann; Kenneth J Smith
Journal:  Brain       Date:  2007-11       Impact factor: 13.501

3.  Axonal damage in acute multiple sclerosis lesions.

Authors:  B Ferguson; M K Matyszak; M M Esiri; V H Perry
Journal:  Brain       Date:  1997-03       Impact factor: 13.501

4.  The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis.

Authors:  Christopher M Holland; Arnaud Charil; Istvan Csapo; Zsuzsanna Liptak; Masanori Ichise; Samia J Khoury; Rohit Bakshi; Howard L Weiner; Charles R G Guttmann
Journal:  J Neuroimaging       Date:  2011-03-29       Impact factor: 2.486

5.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

Authors:  J W Peterson; L Bö; S Mörk; A Chang; B D Trapp
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

Review 6.  The immunopathology of multiple sclerosis: an overview.

Authors:  Hans Lassmann; Wolfgang Brück; Claudia F Lucchinetti
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508

7.  Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood.

Authors:  Christian Skulina; Stephan Schmidt; Klaus Dornmair; Holger Babbe; Axel Roers; Klaus Rajewsky; Hartmut Wekerle; Reinhard Hohlfeld; Norbert Goebels
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

8.  Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.

Authors:  Sung-Min Kim; Mark R Woodhall; Ji-Sun Kim; Seong-Joon Kim; Kyung Seok Park; Angela Vincent; Kwang-Woo Lee; Patrick Waters
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-10-15

9.  Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.

Authors:  Daphne Y S Vogel; Elly J F Vereyken; Judith E Glim; Priscilla D A M Heijnen; Martina Moeton; Paul van der Valk; Sandra Amor; Charlotte E Teunissen; Jack van Horssen; Christine D Dijkstra
Journal:  J Neuroinflammation       Date:  2013-03-04       Impact factor: 8.322

10.  The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Authors:  Josa M Frischer; Stephan Bramow; Assunta Dal-Bianco; Claudia F Lucchinetti; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Hans Lassmann
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

View more
  115 in total

1.  The relationship between corticospinal tract integrity and lower-extremity strength is attenuated when controlling for age and sex in multiple sclerosis.

Authors:  Jessica F Baird; Elizabeth A Hubbard; Bradley P Sutton; Robert W Motl
Journal:  Brain Res       Date:  2018-09-10       Impact factor: 3.252

2.  Human retrovirus pHEV-W envelope protein and the pathogenesis of multiple sclerosis.

Authors:  Robert P Lisak
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-09       Impact factor: 11.205

Review 3.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

Review 4.  Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.

Authors:  Vaibhav Singh; Ajai Tripathi; Ranjan Dutta
Journal:  Proteomics       Date:  2019-06-21       Impact factor: 3.984

5.  miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease.

Authors:  Shukoofeh Torabi; Mona Tamaddon; Mojtaba Asadolahi; Gelareh Shokri; Rezvan Tavakoli; Nooshin Tasharrofi; Reza Rezaei; Vahid Tavakolpour; Hossein Sazegar; Fatemeh Kouhkan
Journal:  Immunogenetics       Date:  2018-10-11       Impact factor: 2.846

Review 6.  The role of B cells in the immunopathogenesis of multiple sclerosis.

Authors:  Tohid Gharibi; Zohreh Babaloo; Arezoo Hosseini; Faroogh Marofi; Abbas Ebrahimi-Kalan; Saeed Jahandideh; Behzad Baradaran
Journal:  Immunology       Date:  2020-05-10       Impact factor: 7.397

Review 7.  Targeting Nuclear Factor-Kappa B Signaling Pathway by Curcumin: Implications for the Treatment of Multiple Sclerosis.

Authors:  Meysam Gachpazan; Sadra Habbibirad; Hoda Kashani; Tannaz Jamialahmadi; Hamid Reza Rahimi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 8.  Role of Myeloid-derived suppressor cell (MDSC) in autoimmunity and its potential as a therapeutic target.

Authors:  Ehsan Nourbakhsh; Ali Mohammadi; Mohammad Salemizadeh Parizi; Atena Mansouri; Farnoosh Ebrahimzadeh
Journal:  Inflammopharmacology       Date:  2021-07-20       Impact factor: 4.473

Review 9.  Mind the gap: from neurons to networks to outcomes in multiple sclerosis.

Authors:  Declan T Chard; Adnan A S Alahmadi; Bertrand Audoin; Thalis Charalambous; Christian Enzinger; Hanneke E Hulst; Maria A Rocca; Àlex Rovira; Jaume Sastre-Garriga; Menno M Schoonheim; Betty Tijms; Carmen Tur; Claudia A M Gandini Wheeler-Kingshott; Alle Meije Wink; Olga Ciccarelli; Frederik Barkhof
Journal:  Nat Rev Neurol       Date:  2021-01-12       Impact factor: 42.937

10.  IFP35 family proteins promote neuroinflammation and multiple sclerosis.

Authors:  Xizhong Jing; Yongjie Yao; Danning Wu; Hao Hong; Xu Feng; Na Xu; Yingfang Liu; Huanhuan Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.